Specific infections, infection-related behavior, and risk of non-Hodgkin lymphoma in adults

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 6, 2006, Pages 1102-1108

  Vajdic, Claire M ^a   Grulich, Andrew E ^a   Kaldor, John M ^a   Fritschi, Lin ^b   Benke, Geza ^c   Hughes, Ann Maree ^d   Kricker, Anne ^e   Turner, Jennifer J ^f   Milliken, Sam ^f   Armstrong, Bruce K ^e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF YORK   (United Kingdom)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ACNE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ETHNOLOGY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFLUENZA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS INFECTION;

ADULT; AGED; AUSTRALIAN CAPITAL TERRITORY; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HUMANS; LYMPHOMA, NON-HODGKIN; LYSSAVIRUS; MALE; MIDDLE AGED; NEW SOUTH WALES; OCCUPATIONAL EXPOSURE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 33745726114     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0078     Document Type: Article

References (50)

1. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia 2001. AIHW cat. no. CAN 23. Canberra: Australian Institute of Health and Welfare; 2004. p. 9.
2. Filipovich AN, Mathur A, Kamut D, Shapiro RS. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992;52:5465-7s.
3. Opelz G, Henderson R. Incidence of non-Hodgkin's lymphoma in kidney and heart transplant recipients. Lancet 1993;342:1514-6.
4. Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S. B-cell non-Hodgkin lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 2004;111:1-8.
5. Morton LM, Engels EA, Holford TR, et al. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women. Cancer Epidemiol Biomarkers Prev 2004;13:425-30.
6. Engels EA, Chatterjee N, Cerhan JR, et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004;111:76-80.
7. Hughes AM, Armstrong BK, Vajdic CM, et al. Pigmentary characteristics, sun-sensitivity and non-Hodgkin lymphoma. Int J Cancer 2004;110:429-34.
8. UNAIDS. Report on the global HIV/AIDS epidemic 2002. Geneva: UNAIDS; 2002.
9. Turner JJ, Hughes AM, Kricker A, et al. WHO non-Hodgkin lymphoma classification by criterion-based report review followed by targeted pathology review: an effective strategy for epidemiology studies. Cancer Epidemiol Biomarkers Prev 2005;14:2213-9.
10. Smith AMA, Rissell CE, Richters J, Grulich AE, de Visser RO. Sex in Australia: sexual identity, sexual attraction, and sexual experience among a representative sample of adults. Aust NZ J Public Health 2003;27:138-45.
11. Fritschi L, Benke G, Hughes AM, et al. Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs. Cancer Causes Control 2005;16:599-607.
12. Fritschi L, Benke G, Hughes AM, et al. Occupational exposure to pesticides and risk of non-Hodgkin lymphoma. Am J Epidemiol 2005;162:849-57.
13. Vrielink H, Reesink H, Habibuw M, Schuller M, van der Meer C, Lelie P. Comparison of four HTLV-I and HTLV-I + II ELISAS. Vox Sang 1999;76:187-91.
14. Hughes AM, Armstrong BK, Vajdic CM, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 2004;112:865-71.
15. Grulich AE, Vajdic CM, Kaldor JM, et al. Birth order, atopy, and risk of non-Hodgkin lymphoma. J Natl Cancer Inst 2005;97:587-94.
16. Grulich AE, Wan X, Law MG, et al. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS 2000;14:133-40.
17. Armenian HK, Hoover DR, Rubb S, et al. Risk factors for non-Hodgkin lymphomas in acquired immunodeficiency syndrome (AIDS). Am J Epidemiol 1996;143:374-9.
18. Holly EA, Lele C. non-Hodgkin lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:211-22.
19. Holly EA, Lele C, Bracci PM, McGrath MS. Case-control study of non-Hodgkin lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 1999;150:375-89.
20. Anttila TI, Lehtinen T, Leinonen M, Bloigu A, Koskela P, Lehtinen M. Serological evidence of an association between chlamydial infections and malignant lymphomas. Br J Haematol 1998;103:150-6.
21. Gachupin-Garcia A, Selwyn PA, Budner NS. Population-based study of malignancies and HIV infection among injecting drug users in a New York City methadone treatment program, 1985-1991. AIDS 1992;6:843-8.
22. Nelson RA, Levine AM, Marks G, Bernstein L. Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma. Br J Cancer 1997;76:1532-7.
23. Zhang Y, Holford TR, Leaderer B, et al. Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol 2004;160:325-30.
24. Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol 2003;26:171-84.
25. Amin J, Gidding H, Gilbert G, et al. Hepatitis C prevalence-a nationwide survey. Commun Dis Intell 2004;28:517-21.
26. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLF-I infection and associated diseases. Oncogene 2005;24:6058-68.
27. Whyte GS. Is screening of Australian blood donors for HTLV-I necessary? Med J Aust 1997;166:478-81.
28. Khuder SA, Schaub EA, Keller-Byrne JE. Meta-analyses of non-Hodgkin lymphoma and farming. Scand J Work Environ Health 1998;24:255-61.
29. McDuffie HH, Pahwa P, Spinelli JJ, et al. Canadian male farm residents, pesticide safety handling practices, exposure to animals and non-Hodgkin lymphoma (NHL). Am J Ind Med Suppl 2002;2:54-61.
30. Fritschi L, Johnson KC, Kliewer EV, Fry R; Canadian Cancer Registries Epidemiology Research Group. Animal-related occupations and the risk of leukemia, myeloma, and non-Hodgkin's lymphoma in Canada. Cancer Causes Control 2002;13:563-71.
31. Becker N, Deeg E, Nieters A. Population-based study of lymphoma in Germany: rationale, study design and first results. Leuk Res 2004;28:713-24.
32. Boffetta P, Gridley G, Gustavsson P, et al. Employment as butcher and cancer risk in a record-linkage study from Sweden. Cancer Causes Control 2000;11:627-33.
33. Travier N, Gridley G, Blair A, Dosemeci M, Boffetta P. Cancer incidence among male Swedish veterinarians and other workers of the veterinary industry: a record linkage study. Cancer Causes Control 2003;14:587-93.
34. Gardner MB. Current information on feline and canine cancers and relationship or lack of relationship to human cancer. J Natl Cancer Inst 1971;46:281-90.
35. Schroeder JC, Olshan AF, Baric R, et al. Agricultural risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma. Epidemiology 2001;12:701-9.
36. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 70:1-492. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon: IARC Press; 1997.
37. Cannon M, Cesarman E. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy. Semin Oncol 2000;27:409-19.
38. Mueller N. Overview of the epidemiology of malignancy in immune deficiency. J Acquir Immune Defic Syndr 1999;21:S5-10.
39. Cartwright RA, McKinney PA, O'Brien C, et al. non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire. Leuk Res 1988;12:81-8.
40. La Vecchia C, Negri E, Franceschi S. Medical history and the risk of non-Hodgkin lymphomas. Cancer Epidemiol Biomarkers Prev 1992;1:533-6.
41. Tavani A, La Vecchia C, Franceschi S, Serraino D, Carbone A. Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas. Fur J Cancer Prev 2000;9:59-64.
42. Franceschi S, Serraino D, Bidoli E, et al. The epidemiology of non-Hodgkin's lymphoma in the north-east of Italy: a hospital-based case-control study. Leuk Res 1989;13:465-72.
43. Doody MM, Linet MS, Glass AG, et al. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control 1992;3:449-56.
44. Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res 1992;53:5510-5s.
45. Holly EA, Bracci PM. Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. Am J Epidemiol 2003;158:316-27.
46. Zhang Y, Holford TR, Leaderer B, et al. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control 2004;15:419-28.
47. Vineis P, Milligi L, Crosignani P, et al. Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health 2000;54:907-11.
48. Paffenberger RS, Wing AL, Hyde RT. Characteristics in youth predictive of adult-onset malignant lymphomas, melanomas, and leukemias [brief communication]. J Natl Cancer Inst 1978;60:89-92.
49. Davis FG, Boice JD, Jr., Hrubec Z, Monson RR. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res 1989;49:6130-6.
50. Askling J, Ekbom A. Risk of non-Hodgkin's lymphoma following tuberculosis. Br J Cancer 2001;84:113-5.